# Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

> **NCT01137630** · PHASE2,PHASE3 · COMPLETED · sponsor: **Moberg Pharma AB** · enrollment: 98 (actual)

## Conditions studied

- Seborrhoeic Dermatitis of the Scalp

## Interventions

- **DRUG:** K40a
- **DRUG:** K40b
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01137630
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2010-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137630, "Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01137630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*